Literature DB >> 26469199

Pioglitazone and bladder cancer.

Hannah Warren1, Nicholas Raison2, Prokar Dasgupta2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26469199     DOI： 10.1111/bju.13352

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  2 in total

Review 1.  Saxagliptin/Dapagliflozin: A Review in Type 2 Diabetes Mellitus.

Authors:  Karly P Garnock-Jones
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) - a study protocol.

Authors:  Dennis Schrijnders; Geertruida H de Bock; Sebastiaan T Houweling; Kornelis J J van Hateren; Klaas H Groenier; Jeffrey A Johnson; Henk J G Bilo; Nanne Kleefstra; Gijs W D Landman
Journal:  BMC Cancer       Date:  2017-06-23       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.